Warning Letters → CMS-684116
Warning Letter CMS-684116 · Issued 2026-07-15
Closed Out (FDA Closeout Letter Issued)
Annovex Pharma Inc — CGMP / Adulterated Pharmaceuticals & Sterile/OTC Drugs Violations (21 CFR 211.84(d)(1), 21 CFR 211.22(a))
Issuing FDA Office: FDA Center for Drug Evaluation and Research (CDER) · Facility FEI: 3020928491
Cited Federal Regulations (Click to Open 21 CFR Clause Encyclopedia):
What FDA Demanded Within 15 Working Days:
Provide a comprehensive independent assessment of your quality unit, complete batch record remediation plan, and retrospective stability/identity testing data within 15 working days.
GMPGraph Forensic Autopsy · Form 483 → Warning Letter Escalation
How This Inspection Escalated Into Formal Enforcement
Est. Remediation & Consultant Cost
$185,000 – $640,000 (Consultant overhaul + retrospective lot testing + delayed SKU launches)
How AI Mock Inspection Prevents This Escalation ($149 vs. $250K+):
Run AI Mock Audit →